Péter Hajdú

Pharmacokinetics of single and multiple doses of clobazam in humans.

W Rupp, M. Badian, O Christ et al. · British Journal of Clinical Pharmacology · 1979 · 101 citations · Full text

Pharmacokinetic Modeling, Pharmacological Study, Multiple Doses +14

Two novel toxins from the Amazonian scorpion Tityus cambridgei that block Kv1.3 and Shaker B K+-channels with distinctly different affinities

César V.F. Batista, Froylán Gómez‐Lagunas, Ricardo C. Rodŕıguez de la Vega et al. · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · 2002 · 91 citations

Biology, Toxinology, Entomology +5

Cholesterol modifies the gating of Kv1.3 in human T lymphocytes

Péter Hajdú, Zoltán Varga, Carlo Pieri et al. · Pflügers Archiv - European Journal of Physiology · 2003 · 90 citations · Full text

Inflammation, Molecular Physiology, Lymphocyte Development +10

Kinetics and metabolism of clobazam in animals and man.

M. Volz, O Christ, HM Kellner et al. · British Journal of Clinical Pharmacology · 1979 · 85 citations · Full text

Margatoxin is a non-selective inhibitor of human Kv1.3 K+ channels

Ádám Bartók, Ágnes Tóth, Sándor Somodi et al. · Toxicon · 2014 · 81 citations · Full text

Molecular Pharmacology, Inhibitory Activity, Signal Transduction +10